ConductScience.org, home

Trial · NCT05049616

Outcomes21

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYNumber of Participants With Stage 2 Hypertension7-10 after deliveryData were not collected for 1 participants in the Hctz/Lisionpril arm. Data were not collected for 8 participants in the extended release nifedipine arm.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants With Severe Postpartum Hypertension7-10 after deliveryParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNumber of Participants Who Received Additional Antihypertensive During Admission7-10 days postpartumParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYPostpartum Length of Stayup to 30 days after deliverydaysMEDIAN
SECONDARYPostpartum Readmissionup to 30 days after deliveryParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYTime to Blood Pressure Control10 daysData were not collected for this outcome measure.
SECONDARYIncidence of Persistent Postpartum Hypertension6 weeks postpartumData were not collected for this outcome measure.
SECONDARYOccurrence of Proteinuria7-10 days, and 6 weeks postpartumData were not collected for this outcome measure
SECONDARYPresense of Labs Abnormality7-10 days, and 6 weeks postpartumData were not collected for this outcome measure
SECONDARYCompliance With Medicationsat the time of the 1st postpartum clinic visit, which is about 6 to 37 days after birthData were not collected for 4 participants in the Hctz/Lisinopril arm. Data were not collected for 8 participants in the Extended release nifedipine armParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYTime to Control Blood Pressure3 month-1 yearData were not collected for this outcome measure.
SECONDARYNumber of Patients Receiving Primary Care With BP Measurement1 year postpartumData were not collected for this outcome because participants were lost to follow up.
SECONDARYPostpartum Complications- Number of Participants With ICU Admission10 days postpartumParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYPostpartum Complications- Number of Participants With HELLP (Hemolysis, Elevated Liver Enzymes and Low Platelets) Syndrome10 days postpartumParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYPostpartum Complications- Number of Participants With Eclampsia10 days postpartumParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYPostpartum Complications- Number of Participants With Stroke10 days postpartumParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYPostpartum Complications- Number of Participants With Renal Failure10 days postpartumParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYPostpartum Complications- Number of Participants With Pulmonary Edema10 days postpartumParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYPostpartum Complications - Number of Participants With Cardiomyopathy10 days postpartumParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYPostpartum Complications- Number of Participants With Maternal Death10 days postpartumParticipantsCOUNT_OF_PARTICIPANTS

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05049616/outcomes